# Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis

> **NCT00094484** · PHASE3 · COMPLETED · sponsor: **Amgen** · enrollment: 400 (—)

## Conditions studied

- Kidney Disease
- Chronic Kidney Disease

## Interventions

- **DRUG:** Cinacalcet HCl

## Key facts

- **NCT ID:** NCT00094484
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 400 (—)
- **Last updated:** 2013-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00094484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00094484, "Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00094484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*